This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katz, J. A. Articles by Henthorn, T. K. Search for Related Content PubMed PubMed Citation Articles by Katz, J. A. Articles by Henthorn, T. K.

The Pharmacokinetics of Bupivacaine When Injected Intra-articularly After Knee Arthroscopy

Received from the Departments of Orthopedic Surgery and Anesthesiology at Northwestern University Medical Center, Chicago, Illinois.

Abstract

Bupivacaine pharmacokinetics were determined in 11 patients receiving the drug intra-articularly after knee arthroscopy performed under general anesthesia. Forty ml 0.25% bupivacaine was given at the end of surgery aid the thigh tourniquet was released 2 to 3 minutes after injection. Blood samples were obtained up to 5 hours after tourniquet release and plasma bupivacaine concentrations were determined. Pharmacokinetic parameters determined were (mean ± SD): volume of distribution (V_d beta) 206 ± 88 L, clearance (Cl) 0.826 ± 0.378 L/min, terminal half-life (T_1/2) beta 189 ± 84 minutes, absorption rate constant (k_a) 9.92 ± 6.79/min, estimated peak plasma concentrations (Cp_max) 0.48 ± 0.20 µg/mL, and time to peak concentration (t_max) 43.4 ± 23.1 minutes. Results indicate that injections of 100 mg bupivacaine intra-articularly after knee arthroscopy produce peak blood concentrations within the first hour after surgery, and that these will be well below concentrations associated with toxic reactions. Peak concentrations can be minimized with shorter tourniquet inflation times and with longer intervals between injection and tourniquet release.

Key Words: PHARMACOKINETICS—intra-articular bupivacaine • SURGERY—arthroscopy

This article has been cited by other articles:

				S. T. Webb and S. Ghosh Intra-articular bupivacaine: potentially chondrotoxic? Br. J. Anaesth., April 1, 2009; 102(4): 439 - 441. [Full Text] [PDF]

				F. Middleton, J. Coakes, S. Umarji, S. Palmer, R. Venn, and S. Panayiotou The efficacy of intra-articular bupivacaine for relief of pain following arthroscopy of the ankle J Bone Joint Surg Br, December 1, 2006; 88-B(12): 1603 - 1605. [Abstract] [Full Text] [PDF]